>U61268.1 Human breast and ovarian cancer susceptibility (BRCA1) gene, exon 2, partial flanking introns, and partial cds
TCGCTAGAACCCGGGAGGCGGAGGTTGCAGTGAGCCGAGATCGCGCCATTGCACTCCAGCCTGGGCGACA
GAGCGAGACTGTCTCAAAACAAAACAAAACAAAACAAAACAAAAAACACCGGCTGGTATGTATGAGAGGA
TGGGACCTTGTGGAAGAAGAGGTGCCAGGAATATGTCTGGGAAGGGGAGGAGACAGGATTTTGTGGGAGG
GAGAACTTAAGAACTGGATCCATTTGCGCCATTGAGAAAGCGCAAGAGGGAAGTAGAGGAGCGTCAGTAG
TAACAGATGCTGCCGGCAGGGATGTGCTTGAGGAGGATCCAGAGATGAGAGCAGGTCACTGGGAAAGGTT
AGGGGCGGGGAGGCCTTGATTGGTGTTGGTTTGGTCGTTGTTGATTTTGGTTTTATGCAAGAAAAAGAAA
ACAACCAGAAACATTGGAGAAAGCTAAGGCTACCACCACMTACCCGGTCAGTCACTCCTCTGTAGCTTTC
TCTTTCTTGGAGAAAGGAAAAGACCCAAGGGGTTGGCAGCGATATGTGAAAAAATTCAGAATTTATGTTG
TCTAATTACAAAAAGCAACTTCTAGAATCTTTAAAAATAAAGGACGTTGTCATTAGTTCTTTGGTTTGTA
TCATTCTAAAACCTTCCAAATCTTAAATTTACTTTATTTTAAAATGATAAAATGAAGTTGTCATTTTATA
AACCTTTTAAAAAGATATATATATATGTTTTTCTAATGTGTTAAAGTTCATTGGAACAGAAAGAAATGGA
TTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCC
ATCTGGTAAGTCAGCACAAGAGTGTATTAATTTGGGATTCCTATGATTATCTCCTATGCAAATGAACAGA
ATTGACCTTACATACTAGGGAAGAAAAGACATGTCTAGTAAGATTAGGCTATTGTAATTGCTGATTTTCT
TAACTGAAGAACTTTAAAAATATAGAAAATGATTCCTTGTTCTCCATCCACTCTGCCTCTCCCACTCCTC
TCCTTTTCAACACAAATCCTGTGGTCCGGGAAAGACAGGGCTCTGTCTTGATTGGTTCTGCACTGGGGCA
GGAATCTAGTTTAGATTAACTGGCATTTTGGCTTTTCTTCCAGCTCTAAAACAAGCTCCATCACTTGAAA
TGGCAAAATAAAATCATGGATGAGGCCGAGGGCGGTGGCTTACGCCTGTAATCCCAGCACTTTGGGAGGC
CAAGGTGGTAGGATCACGAGGTCAGGAGATCGAGACCATCCTGGCCAACATGGTGAAAACCCCCTCTCCA
CTAAAAAT

